Omega-3 polyunsaturated fatty acids and the psychiatric post-acute sequelae of COVID-19: A one-year retrospective cohort analysis of 33,908 patients
CONCLUSION: Omega-3 PUFAs may require re-evaluation as a preventive strategy against adverse mental health outcomes post-COVID-19 in placebo-controlled clinical trials.PMID:37716377 | DOI:10.1016/j.bbi.2023.09.008
Source: Brain, Behavior, and Immunity - Category: Neurology Authors: Ting-Hui Liu Chung-Han Ho Daniel Tzu-Li Chen Jheng-Yan Wu Po-Yu Huang Chih-Cheng Lai Kuang-Yang Hsieh Kuan-Pin Su Source Type: research
More News: Anxiety | Brain | Clinical Trials | Cough | Covid Vaccine | COVID-19 | Depression | Disability | Electronic Health Records (EHR) | Headache | Insomnia | Lovaza | Men | Migraine | Neurology | Omega 3 | Pain | Pain Management | Psychiatry | Study | Vaccines